Results 331 to 340 of about 112,568 (383)

Human Platelet Lysate Treatment for Exposure Keratopathy: An In Vivo Confocal Microscopy and Anterior Segment OCT Study. [PDF]

Invest Ophthalmol Vis Sci
Tsai CY, Huang WL, Yang SC, Huang BD, Klochkov V, Liao SL, Wu AY, Chen WL.   +7 more
europepmc   +1 more source

Rhinosporidiosis of the conjunctiva.

Journal of the All-India Ophthalmological Society, 1965
Hafeez M, Tandon P
openaire   +2 more sources

Utilizing Cordyceps cicadae Mycelium as a Potential Supplement for Alleviating UVB‐Induced Photokeratitis Symptoms In Vivo

eFood, Volume 6, Issue 4, August 2025.
Cordyceps cicadae mycelium extracts (CCME) have been reported to exert beneficial effects on ocular diseases. TV, TBUT, and cornea surface indexes were improved with oral CCME intake. Immunohistochemical assays showed that p63 + , PCNA, NF‐κB and COX‐2 expressions decreased in the CCME group than that of the UVB group. The corneas of those treated with
Tsung‐Han Lu, Szu‐Yu Kuo, Jui‐Hsia Hsu, Yen‐Lien Chen, Han‐Hsin Chang, Chin‐Chu Chen, David Pei‐Cheng Lin   +6 more
wiley   +1 more source

Small lymphocytic lymphoma presenting as bilateral medial lower eyelid ectropion. [PDF]

Am J Ophthalmol Case Rep
Anchouche S, Chang K, Yao CM, Hojilla C, Nijhawan N, Nassrallah G.   +5 more
europepmc   +1 more source

Mechanistic Insights and Pharmacological Approaches for Nitrogen and Sulfur Mustards and Their Implications as Therapeutic Agents

Journal of Applied Toxicology, Volume 45, Issue 8, Page 1417-1425, August 2025.
ABSTRACT Nitrogen and sulfur mustards, often acting as vesicants, have significant consequences for public health. Skin is a common site for exposure to these vesicants that can result in considerable morbidity and mortality. Given that the treatment options are limited, new insights into the mechanisms for the toxicity of these vesicants that can be ...
Madison Owens, Anita Thyagarajan, Jeffrey B. Travers, Ravi P. Sahu   +3 more
wiley   +1 more source

Ocular Surface Involvements in the Development of Sjögren's Syndrome-Associated Dry Eye in the IL14α Transgenic Mouse. [PDF]

Invest Ophthalmol Vis Sci
Zhang M, Liang Y, Wu H, Zong R, Zhang X, He H, Reinach PS, Liu Z, Shen L, Li W.   +9 more
europepmc   +1 more source

Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market

Acta Ophthalmologica, Volume 103, Issue 5, Page 586-608, August 2025.
Abstract Purpose To provide an overview of artificial tears marketed in the following Nordic countries: Denmark, Finland, Norway, Iceland and Sweden. Furthermore, this review aimed to highlight the different preservatives and other constituents found in artificial tears in the Nordic market, focussing on adverse effects.
K. N. Mikha, C. E. Ø. Rasmussen, S. N. G. Ahrensberg, J. Freiberg, R. A. Wozniak, U. M. K. Alnoor, F. Fineide, T. P. Utheim, S. Heegaard, M. Kolko   +9 more
wiley   +1 more source

Tear IgE point-of-care testing for differentiating type I and type IV allergic conjunctivitis. [PDF]

Front Med (Lausanne)
Shang X, Zhang Y, Luo S, Liu M, Li H, Fang X, Xie Z, Xiao X, Yang Z, Lin Y, Wu H.   +10 more
europepmc   +1 more source

Long‐term results after sutureless intrascleral fixation of the Carlevale intraocular lens: Changes in scleral pocket thickness over time

Acta Ophthalmologica, Volume 103, Issue 5, Page e290-e297, August 2025.
Abstract Purpose To investigate the long‐term effects and dynamic changes in scleral thickness above the T‐haptic after sutureless scleral‐fixated intraocular lens (sSFIOL) implantation using the FIL‐SFF Carlevale lens. Setting Single‐centre, single‐surgeon, prospective clinical trial, Department of Ophthalmology, Medical University of Vienna, Austria.
Markus Schranz, Ioanna Dimakopoulou, Marcus Lisy, Victor Danzinger, Daniel Schartmüller, Claudette Abela‐Formanek   +5 more
wiley   +1 more source

Clinical outcomes of pterygium surgery over a ten-year period: a review of recurrence and complication rates. [PDF]

BMC Ophthalmol
Noguera SI, Nicanor KSA, Ang RET, Cruz EM.   +3 more
europepmc   +1 more source